Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003
<p>Abstract</p> <p>Background</p> <p>Some Chinese herbal products (CHPs) may contain aristolochic acid (AA) or may be adulterated by the herbs suspected of containing AA which is nephrotoxic and carcinogenic. This study aims to identify the risk and the prescription pro...
Main Authors: | Lee Chang-Hsing, Tseng Wei-Lum, Lin I-Hsin, Hsieh Shu-Ching, Wang Jung-Der |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-10-01
|
Series: | Chinese Medicine |
Online Access: | http://www.cmjournal.org/content/3/1/13 |
Similar Items
-
Assessment of nephrotoxicity of herbal medicine containing aristolochic acid in mice
by: Yi Quan, et al.
Published: (2020-03-01) -
Prescription profile of Chinese herbal products containing coumestrol, genestein, and/or daidzein among female users: an analysis of national health insurance data in Taiwan between 1997 and 2007
by: Wu Chien-Tung, et al.
Published: (2012-10-01) -
Increased risk of urinary tract cancer in ESRD patients associated with usage of Chinese herbal products suspected of containing aristolochic acid.
by: Shuo-Meng Wang, et al.
Published: (2014-01-01) -
Chinese herbal products highly suspected to contain aristolochic acid and the development of chronic renal disease or urinary tract cancer
by: Ming-Nan Lai, et al.
Published: (2010) -
The association of chronic kidney disease and traditional Chinese herbal products suspected to contain aristolochic acid after the prohibition by law
by: Yen He Chen, et al.
Published: (2011)